Olga Maria Nardone - Concepedia

Author

Olga Maria Nardone

Also Known As

Fabiana Castiglione, Nardone, O.M., Nardone,Olga Maria, O M Nardone, O NARDONE, O Nardone, O. Nardone, O.M. Nardone, Olga M Nardone, Olga M. NARDONE

212

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

University of Naples Federico II Federico II University Hospital University of Birmingham APC Microbiome Institute NIHR Birmingham Biomedical Research Centre

About

Olga Maria Nardone is an author at University of Naples Federico II specializing in medicine, gastroenterology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	500
2	Health Sciences	2	2	35
3	Public Health	1	1	30
4	Clinical Nutrition	1	1	23
5	Emergency Medicine	1	1	35

Olga Maria Nardone

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
One‐year clinical outcomes with biologics in Crohn's disease: transmural healing compared with mucosal or no healing Fabiana Castiglione, Nicola Imperatore, Anna Testa, Alimentary Pharmacology & Therapeutics	2019	185
Cross-sectional evaluation of transmural healing in patients with Crohn’s disease on maintenance treatment with anti-TNF alpha agents Fabiana Castiglione, Pier Paolo Mainenti, Anna Testa, Digestive and Liver Disease InflammationAnti-tnf Alpha AgentsTransmural HealingAnti-inflammatoryMedicine	2017	109
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year Luisa Guidi, Manuela Marzo, Gianluca Andrisani, Digestive and Liver Disease InflammationMucosal HealingMucosal ImmunologyGastrointestinal PharmacologyMedicine	2014	87
An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis Marietta Iacucci, Samuel C. Smith, Alina Bazarova, Gastroenterology GastroenterologyPathologyDiagnosisClinical GastroenterologySurgery	2021	76
Long-term Combination Therapy with Infliximab Plus Azathioprine Predicts Sustained Steroid-free Clinical Benefit in Steroid-dependent Ulcerative Colitis Alessandro Armuzzi, Daniela Pugliese, Silvio Danese, Inflammatory Bowel Diseases	2014	70
A virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic activity/remission and predict clinical outcomes in ulcerative colitis Rosanna Cannatelli, Tommaso Lorenzo Parigi, Marietta Iacucci, Endoscopy	2022	66
Endoscopic Postoperative Recurrence in Crohn’s Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study Henit Yanai, A Kagramanova, O. V. Knyazev, Journal of Crohn s and Colitis	2022	59
Impact of COVID-19 outbreak on clinical practice and training of young gastroenterologists: A European survey Giovanni Marasco, Olga Maria Nardone, Marcello Maida, Digestive and Liver Disease	2020	54
Bowel Damage in Crohnʼs Disease Antonio Rispo, Nicola Imperatore, Anna Testa, Inflammatory Bowel Diseases	2016	51
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors Sara Onali, Daniela Pugliese, Flavio Caprioli, The American Journal of Gastroenterology	2022	46

Page 1